Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Accounts Payables: 2020-2023

Historic Accounts Payables for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $5.2 million.

  • Therapeutics' Accounts Payables fell 73.95% to $1.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.4 million, marking a year-over-year decrease of 73.95%. This contributed to the annual value of $5.2 million for FY2023, which is 53.82% up from last year.
  • Per Therapeutics' latest filing, its Accounts Payables stood at $5.2 million for FY2023, which was up 53.82% from $3.4 million recorded in FY2022.
  • In the past 5 years, Therapeutics' Accounts Payables registered a high of $5.2 million during FY2023, and its lowest value of $2.0 million during FY2021.
  • For the 3-year period, Therapeutics' Accounts Payables averaged around $3.5 million, with its median value being $3.4 million (2022).
  • As far as peak fluctuations go, Therapeutics' Accounts Payables dropped by 16.11% in 2021, and later surged by 68.33% in 2022.
  • Therapeutics' Accounts Payables (Yearly) stood at $2.4 million in 2020, then decreased by 16.11% to $2.0 million in 2021, then spiked by 68.33% to $3.4 million in 2022, then spiked by 53.82% to $5.2 million in 2023.